Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference235 articles.
1. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020
2. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium;Böttcher;J. Virol.,2006
3. TMPRSS2 and COVID-19: serendipity or opportunity for intervention?;Stopsack;AACR,2020
4. Emerging coronaviruses: genome structure, replication, and pathogenesis;Chen;J. Med. Virol.,2020
5. Coronaviruses: An Overview of their Replication and Pathogenesis, Coronaviruses;Fehr,2015
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparable clinical advantages identification of three formulae on rheumatic disease using a modular-based network proximity approach;Journal of Ethnopharmacology;2025-01
2. In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19;Phytomedicine;2024-07
3. A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein;The Nucleus;2024-05-22
4. Emetine induces oxidative stress, cell differentiation and NF-κB inhibition, suppressing AML stem/progenitor cells;Cell Death Discovery;2024-04-29
5. Sodium Cromolyn Modulates Carrageenan-Induced Acute Inflammation Through the Interleukin-6 Levels;Jundishapur Journal of Natural Pharmaceutical Products;2024-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3